Back

Revisiting the Definition of Acral Melanoma: Unraveling Histology and Location

Beagles, E.; Khattab, S.; Burke, O. M.; Mahajan, A.; Ciampa, D.; Xu, S.; Thang, C.; Moseley, C.; Wan, G.; Chang, C.; Lu, C.; Nguyen, N.; Hartman, R. I.; Asgari, M. M.; DeSimone, M.; Hurlbert, M. S.; Semenov, Y.

2025-06-25 dermatology
10.1101/2025.06.24.25330235 medRxiv
Show abstract

Acral melanoma (AM) is a rare subtype of melanoma associated with poor prognosis. However, inconsistent definitions--based on either anatomic location (e.g., palms, soles, subungual areas) or histopathologic subtype (e.g., acral lentiginous melanoma)--complicate prognostication, hinder treatment decision-making, and pose challenges for both clinical and translational research. This multi-institutional retrospective cohort study aimed to determine whether anatomic location or histologic subtype better predicts outcomes in AM. Distal extremity primary melanomas (n = 469) were matched 1:2 with cutaneous melanomas (CMs; n = 938). Cox proportional hazards models evaluated recurrence-free survival (RFS), melanoma-specific survival (MSS), and overall survival (OS). Of the distal tumors, 280 (59.7%) were ALMs, including 33 (11.8%) on non-subungual dorsal sites. Compared to CMs, acral surface melanomas had worse outcomes, while dorsal melanomas had similar outcomes, independent of histology. ALMs were associated with worse survival than superficial spreading melanomas (SSMs). In interaction models, ALMs on dorsal surfaces and all histologic subtypes on acral surfaces had worse MSS than non-distal SSMs. A revised definition of AM may better inform clinical management and future research.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
30.5%
2
Experimental Dermatology
10 papers in training set
Top 0.1%
7.7%
3
JID Innovations
11 papers in training set
Top 0.1%
7.7%
4
European Journal of Cancer
11 papers in training set
Top 0.1%
5.5%
50% of probability mass above
5
Scientific Reports
3612 papers in training set
Top 17%
5.4%
6
Annals of Oncology
14 papers in training set
Top 0.1%
5.4%
7
British Journal of Dermatology
11 papers in training set
Top 0.1%
4.2%
8
PLOS ONE
5266 papers in training set
Top 35%
4.0%
9
Journal of Investigative Dermatology
49 papers in training set
Top 0.2%
3.2%
10
BMC Cancer
67 papers in training set
Top 0.7%
3.1%
11
JNCI: Journal of the National Cancer Institute
19 papers in training set
Top 0.1%
2.3%
12
Cancers
213 papers in training set
Top 3%
2.1%
13
JAMA Network Open
130 papers in training set
Top 2%
1.5%
14
Nature Medicine
125 papers in training set
Top 2%
1.4%
15
eClinicalMedicine
77 papers in training set
Top 1%
1.1%
16
Nature Communications
5641 papers in training set
Top 52%
1.1%
17
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 2%
1.0%
18
Biology Open
156 papers in training set
Top 4%
0.8%
19
Frontiers in Oncology
103 papers in training set
Top 3%
0.8%
20
Communications Biology
993 papers in training set
Top 32%
0.8%
21
Eye
11 papers in training set
Top 0.3%
0.8%
22
Frontiers in Medicine
120 papers in training set
Top 4%
0.8%
23
Blood Advances
62 papers in training set
Top 1%
0.8%
24
Frontiers in Immunology
638 papers in training set
Top 11%
0.6%